Eli Lilly & Co. (LLY) Raises Quarterly Dividend 2% to $0.51; 2.4% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Lilly (LLY) Shows Incremental Growth Opportunities - Piper Jaffray
December 9, 2015 7:42 AM ESTPiper Jaffray analyst, Richard Purkiss, attended a Eli Lilly (NYSE: LLY) investor day specifically addressing Elanco, its animal heath business, and its Alzheimer's disease portfolio. He came away with a deeper understanding of Elanco's growth drivers and believes this business could spur upgrades from other banks. Also, the depth and breadth of LLY's Alzheimer's portfolio beyond solanezumab was a clear upside surprise.
The wider animal health... More
